Catheter Precision, Inc. Announces Definitive Agreement to Acquire PeriKard, LLC
Portfolio Pulse from
Catheter Precision, Inc. (NYSE American: VTAK) has announced a definitive agreement to acquire PeriKard, LLC. The acquisition will be completed through the issuance of restricted VTAK common stock for 100% of PeriKard's LLC interests.
January 15, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Catheter Precision, Inc. is acquiring PeriKard, LLC by issuing restricted common stock. This strategic move could enhance VTAK's product offerings in the electrophysiology market.
The acquisition of PeriKard, LLC by Catheter Precision, Inc. is a strategic move to expand its product offerings in the electrophysiology market. The transaction involves issuing restricted VTAK common stock, which may lead to a positive short-term impact on VTAK's stock price due to potential growth opportunities and market expansion.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100